Clinical Trial Update: Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS [NA]

View source ↗

Summary

Completed clinical trial evaluating minimal residual disease in diffuse large B-cell lymphoma using cell-free circulating DNA detected by next-generation sequen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Non Hodgkin Lymphoma | NA | Status: COMPLETED